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Obesity and atherosclerosis-related diseases ac-
count for over one-third of deaths in the western
world. Controlling these conditions remains a major
challenge due to an incomplete understanding of
the molecular pathways involved. Here, we show
that Wip1 phosphatase, a known negative regulator
of Atm-dependent signaling, plays a major role in
controlling fat accumulation and atherosclerosis in
mice; specifically, Wip1 deficiency prevents both
conditions. In the course of atherosclerosis, deletion
of Wip1 results in suppression of macrophage con-
version into foam cells, thus preventing the formation
of atherosclerotic plaques. This process appears to
be independent of p53 but rely on a noncanonical
Atm-mTOR signaling pathway and on selective
autophagy in regulation of cholesterol efflux. We
propose that the Wip1-dependent control of autoph-
agy and cholesterol efflux may provide avenues for
treating obesity and atherosclerosis.
INTRODUCTION
In the United States alone, up to 33.7%of adults are classified as
obese, and cardiovascular diseases were responsible for 33.6%
of deaths in 2010 (Roger et al., 2011). Atherosclerosis, a progres-
sive disease of the large arteries that is influenced by multiple
genetic and environmental risk factors, is an underlying cause
of many cardiovascular diseases. The initiating step in athero-
sclerosis development is the oxidation of low-density lipoprotein
molecules (LDL) by free radicals (Hansson and Libby, 2006).
When oxidized LDL (oxLDL) comes in contact with an artery
wall, the artery is damaged. This initiates a series of reactions
to repair it, including recruitment of monocytes, which are then
influenced to differentiate into macrophages by the surrounding
secreted macrophage colony stimulating factors. These macro-
phages ingest oxLDL, leading to intracellular cholesterol accu-
mulation in the form of lipid droplets and the formation of foam
cells (Glass and Witztum, 2001). As macrophages are not able
to process oxLDL, they grow and ultimately rupture, depositing
additional oxidized cholesterol into the artery wall. This triggers
further immune response, continuing the cycle. Eventually, the
artery becomes inflamed, and the plaque causes the muscle68 Cell Metabolism 16, 68–80, July 3, 2012 ª2012 Elsevier Inc.cells to enlarge and form a hard cover over the affected area,
thus narrowing the artery and reducing the blood flow. In aggres-
sive cases, this can further provoke stroke and heart attack
(Glass and Witztum, 2001).
Wip1 phosphatase is emerging as a potent regulator of
tumorigenesis. TheWIP1 gene is amplified in numerous primary
human tumors (Bulavin et al., 2002; Rauta et al., 2006; Saito-
Ohara et al., 2003), and deletion of Wip1 results in a tumor-
resistant phenotype in several cancer-prone mouse models
(Bulavin et al., 2004; Shreeram et al., 2006a; Demidov et al.,
2007). Studies have shown that Wip1-dependent regulation of
Atm is key in the activation of tumor suppressor, p53, and subse-
quent suppression of tumorigenesis (Shreeram et al., 2006b;
Batchelor et al., 2008). ATM is mutated in patients with ataxia
telangiectasia (A-T), a recessive disease manifested by different
clinical pathologies (Wu et al., 2005; Lavin, 2008; Schneider
et al., 2006). Atm gene deficiency was also recently associated
with metabolic disorders, such an excess adiposity, increased
blood pressure, atherosclerosis, glucose intolerance, and insulin
resistance inmouse studies (Schneider et al., 2006); 0.5%–2%of
humans with ATM heterozygosity are at increased risk of death
from ischemic heart disease (Su and Swift, 2000). p53 has also
been implicated in regulation of atherogenesis in several mouse
models (Guevara et al., 1999; van Vlijmen et al., 2001).
In this study, we describe a role for Wip1 in controlling obesity
and atherosclerosis, which appears to be dependent on an Atm-
mTOR signaling pathway. Using a series of genetic crosses, we
found that Wip1 deficiency suppresses fat accumulation when
mice are fed with a high-fat diet and prevents atherosclerosis
in an apoE-deficient background. We further found that forma-
tion of lipid droplets, and thus conversion of macrophages
into foam cells, is suppressed in Wip1-deficient mice through
autophagy-dependent regulation of cholesterol efflux. Our study
shows the in vivo significance of Wip1-dependent regulation of
autophagy in the regulation of fat accumulation in macrophages
and atherosclerosis and thus provides interesting prospects for
therapeutic interventions.
RESULTS
Wip1 Promotes Diet-Induced Weight Gain and Fat
Accumulation
Wip1 phosphatase is a known regulator of Atm and p53, both of
which have been implicated in regulation of atherosclerosis
(Guevara et al., 1999; Schneider et al., 2006; Shreeram et al.,
2006a, 2006b). Analysis of Wip1’s role in atherosclerosis thus
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tion as well as to uncover new molecular networks governed by
Wip1. To assess the effects of Wip1 on atherosclerosis, we
crossed Wip1/ mice with atherosclerosis-prone apolipopro-
tein E knockout mice (apoE/), both in the C57BL/6 back-
ground. Subsequently, the apoE/ Wip1+/ mice were inter-
crossed; apoE/ Wip1/ and apoE/ littermates were used
for further analyses. ApoE/ Wip1/ offspring were born at
a lower than expected frequency (10% versus expected 25%
in intercrossed apoE/ Wip1+/ mice), which was in line with
the previously established Mendelian ratio disturbance for
Wip1/ animals (Figure S1) (Choi et al., 2002). Analyses of
weight measurements during feeding of apoE/ and apoE/
Wip1/ mice with a western diet (42% kcal in fat) for 8 weeks
showed reduced weight gain in both male and female apoE/
Wip1/ mice (Figures 1A and 1B). After 8 weeks on this diet,
apoE/ Wip1/ males and females gained averages of 3 g
and 3.5 g, respectively, versus 7 g for male and 7.2 g for female
apoE/ animals (Figures 1A and 1B). This suppression of weight
gain was dependent on the presence of both mutant Wip1
alleles, as apoE/Wip1+/ males displayed weight gain similar
to apoE/males (Figure 1A). In order to assess if this resistance
to weight gain could be reproduced in a nonsensitized mouse
background, C57BL/6 Wip1+/ mice were intercrossed, and
wild-type and Wip1/ littermates were placed on a high-fat
diet (60.3% kcal in fat). Analysis of weight measurements taken
over the course of 12 weeks revealed a significantly reduced
weight increase in Wip1/ versus wild-type males (Figure 1C).
Wip1/ females showed a difference only during the first
5 weeks of the feeding protocol (Figure 1D), which is in line
with the previous observation that female mice are less sensitive
to weight gain (Nishikawa et al., 2007).
To understand whether the difference in weight gain between
apoE/ Wip1/ and apoE/ mice (Figures 1A–1D) correlated
with reduced fat accumulation, we conducted a full body MRI
and analysis of visceral fat pads. The MRI revealed a significant
reduction in the absolute amount and percentage of body fat
in apoE/ Wip1/ versus apoE/ mice in both males and
females (Figure 1E). In agreement with this observation, we
also found a significant reduction in the size of visceral fat
pads in apoE/ Wip1/ mice (Figure 1F). After 8 weeks of
western diet feeding, the livers of apoE/ Wip1/ mice were
significantly lighter (Figure 1G) and histologically negative when
stained with oil red O (Figure 1H), suggesting that steatosis
was suppressed.
To investigate the potential mechanism(s) of Wip1-dependent
control of fat accumulation, we carried out a detailed analysis of
food intake and energy metabolism usingmetabolic cages. Mice
were analyzed after being fed a western diet for 6 weeks. We
observed decreased food intake in apoE/ Wip1/ mice (Fig-
ure 2A) as well as an increase in their physical activity at night
compared to apoE/ littermates (Figure 2B). Analysis of
apoE/Wip1/mice using metabolic cages revealed a drastic
increase in VO2 consumption, accompanied by an increase in
VCO2 production, in apoE
/ Wip1/ mice, suggesting in-
creased energy expenditure (Figures 2C and 2D). Importantly,
the respiratory exchange ratio at day time for apoE/ Wip1/
mice was close to 0.71, suggesting an intensified usage of fat
as a source of energy (Figure 2E). Overall, these findings suggestthat Wip1 deletion accelerates the metabolic rate in apoE/
mice.
Wip1 Promotes Atherosclerosis
After completing an 8 week western diet protocol, both apoE/
and apoE/ Wip1/ mice were subjected to rigorous analysis
for atherosclerosis. We found that atherosclerosis formation
was significantly suppressed in apoE/Wip1/mice. Analysis
of Sudan red-stained aortas showed that the number of athero-
sclerotic lesions was significantly lower in apoE/ Wip1/
when compared with apoE/ mice (Figures 3A and 3B). Next
we sectioned aortas at the base of aortic root and found that
the mean area of atherosclerotic lesions was also significantly
smaller in apoE/Wip1/ compared to apoE/mice (Figures
3C and 3D). Significant differences in formation of atheroscle-
rotic lesions between genotypes also were observed after
14 weeks of feeding (Figure S2). Analysis of atherosclerotic pla-
que formation histologically is based on Sudan red staining
(Figures 3A–3D) and is a reflection of reduced fat deposition
in vivo. In turn, macrophage foam cells are a major source of
fat deposition in atherosclerotic plaques (Glass and Witztum,
2001; Paul et al., 2008). To understand whether accumulation
of cholesterol in apoE/ Wip1/ mice is reduced in vivo, we
next purified peritoneal macrophages from mice that had been
on a western diet for 8 weeks. We found a significant reduction
in the amount of free cholesterol and cholesteryl esters in
macrophages obtained from apoE/Wip1/mice when com-
pared with apoE/ mice (Figure 3E). Consistent with reduced
number and size of atherosclerotic lesions, we also found that
apoE/ Wip1/ mice had a significantly lower systolic blood
pressure compare to apoE/ mice (Figure 3F), further support-
ing a role for Wip1 in the development of different aspects of
cardiovascular disease in an apoE/ mouse model of
atherosclerosis.
Wip1 Deficiency Suppresses Macrophage Conversion
into Foam Cells
Wip1-deficient mice exhibited reduced food intake (Fig-
ure 2A); however, the concentrations of circulating plasma fatty
acids (0.626 ± 0.272 mmol/l for apoE/ versus 0.5798 ±
0.164 mmol/l for apoE/Wip1/) and total cholesterol in frac-
tions of HDL (0.387 ± 0.288 mg/ml for apoE/ versus 0.280 ±
0.196 mg/ml for apoE/ Wip1/) and LDL (7.20 ± 2.35 mg/ml
for apoE/ versus 6.89 ± 1.58 mg/ml for apoE/ Wip1/)
were not significantly different between genotypes. We further
carried out a lipoprotein profiling by an NMR analysis in plasma
obtained from apoE/ and apoE/ Wip1/ mice that have
been on a western diet for 8 weeks. We found no difference in
concentration and particle size of different fractions of VLDL,
LDL, HDL, and IDL (Figure S3). Reduction in atherosclerotic pla-
que formation in apoE/Wip1/mice, as determined histolog-
ically based on Sudan red staining (Figures 3A–3D), is merely
a reflection of reduced fat deposition, which is dependent on
formation of foam cells, a major source of fat deposition in
atherosclerotic lesions (Glass and Witztum, 2001; Paul et al.,
2008). To understand whether Wip1 was involved in atheroscle-
rosis regulation at this very early stage, we next adopted an
in vitro system to analyze macrophage conversion into foam
cells. Bone marrows were collected from apoE/ or apoE/Cell Metabolism 16, 68–80, July 3, 2012 ª2012 Elsevier Inc. 69
Figure 1. Deficiency of Wip1 Protects from Fat Diet-Induced Obesity
(A and B) Body weights of mice of different genders in apoE/ background show a reduced body weight of Wip1/mice fed with western diet (apoE/Wip1/
versus apoE/ Wip1+/ versus apoE/ males, n = 8/5/8; and apoE/Wip1/versus apoE/ females, n = 10/10).
(C) Reduced body weight of male Wip1/mice fed with high-fat diet (Wip1/ versus Wip1+/+ males, n = 9/9). Total weight gained after 11 weeks of high-fat diet
feeding is shown (right panel).
(D) Female Wip1/ mice showed a difference in body weight only within the first 5 weeks (n = 8 for both groups).
(E) Body fat composition analysis using theMRI after 8 weeks of western diet feeding for apoE/Wip1/ versus apoE/males (n = 8/8) and females (n = 10/10).
(F) Representative pictures of visceral fat pads from apoE/ and apoE/ Wip1/ males.
(G) Liver weight analysis after 8 weeks western diet feeding for apoE/ Wip1/ versus apoE/ males (n = 8/8) and females (n = 10/10).
(H) The 203 magnification of liver sections stained with oil red O from apoE/ and apoE/ Wip1/ males isolated after 8 weeks of western diet. Values are
mean ± SEM.
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Figure 2. Metabolic Cage Analysis of
apoE–/– and apoE–/– Wip1–/– Males Placed
on a Western Diet
(A) Food intake in a day and night cycle for
apoE/ versus apoE/Wip1/ mice.
(B) Physical activity is depicted as the average
total count per day or night cycle.
(C and D) The volume of O2 consumed and CO2
producedwasmeasured over a night or day cycle.
(E) The respiratory exchange ratio (RER) was as-
sessed during the day and night cycles. Values are
mean ± SEM.
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Wip1 Controls Obesity and AtherosclerosisWip1/ mice and were used to induce the differentiation into
macrophages in the presence of conditioned medium from
L929 cells expressing granulocyte macrophage colony stimu-
lating factor (Weischenfeldt and Porse, 2008). The 5 day differen-
tiation protocol yielded about 60%macrophages, as determined
by FACS with surface-specific marker CD11b; this was similar
for bonemarrows from apoE/ and apoE/Wip1/mice (Fig-
ure S4A). Next, we incubated the obtained macrophage cultures
with increasing concentrations of oxLDL to induce foam cell
formation. The oil red O staining of apoE/-derived macro-
phages showed an increasing accumulation of foam cells after
treatment with 5–20 mg of oxLDL; apoE/ Wip1/ foam cells
were also present, but the accumulation was markedly reduced
(Figure S4B, Figure 4A). We further found a significant reduction
in foam cell formation as well as accumulation of cholesteryl
esters in apoE/Wip1/macrophages treated with acetylated
and aggregated LDLs as well as VLDL (Figure 4A). We also
observed that macrophage viability using MTT test was compa-
rable between different genotypes in the presence of different
types of LDL and VLDL (data not shown). These data stronglyCell Metabolism 16,suggest that foam cell formation is
dependent on the presence of Wip1.
To assess potential molecular players
responsible for the observed reduction in
foam cell formation, we treated apoE/
Wip1/ macrophages with various
chemical inhibitors. Previous analyses
revealed that Wip1 regulates p38MAPK
and Atm-dependent signaling path-
ways (Takekawa et al., 2000; Shreeram
et al., 2006b). While the p38 inhibitor
SB202190 had no effect on foam cell
formation in apoE/ Wip1/ macro-
phages, the Atm inhibitor KU55433 com-
pletely reversed the inhibitory effect of
Wip1 deficiency (Figure 4B).
We next used a genetic approach to
determine the molecular targets down-
stream of Atm that played a role in
controlling foam cell formation. We es-
tablished macrophage cultures from
apoE/ Wip1/ mice that also either
lacked one allele of Atm or were deficient
for one of Atm’s downstream targets,
Chk2 or p53. Wip1 has been previously
implicated in a negative regulation ofAtm (Shreeram et al., 2006a, 2006b), and we found that the level
of Atm phosphorylation as well as p53 phosphorylation at Atm
site Ser18 (human Ser15) were increased in apoE/ Wip1/
macrophages when compared to apoE/ cells (Figure 4C). In
turn, disruption of a single Atm allele was sufficient to reverse
the phosphorylation of p53 at Atm site Ser18 (Figure 4C) and
to block the inhibitory effect of Wip1 deficiency on foam cell
formation and accumulation of cholesteryl esters, while a full
knockout of either p53 or Chk2 had no effect (Figure 4D). Thus,
Wip1 deficiency suppresses macrophage conversion into foam
cells in an Atm- but not p53- or Chk2-dependent manner.
Wip1-Dependent Control of Atm, but Not p53, Mediates
Resistance to Weight Gain and Atherosclerosis
Our analysis revealed a key role of Atm, but not p53, in regula-
tion of foam cell formation in apoE/ Wip1/ macrophages
(Figure 4D). To determine whether our in vitro results would
be translated into in vivo effects of Atm and p53 on Wip1-
dependent suppression of weight gain and atherosclerosis, we
crossed apoE/ Wip1/ with either Atm/ or p53/ mice.68–80, July 3, 2012 ª2012 Elsevier Inc. 71
Figure 3. Wip1 Deficiency Prevents Athero-
sclerosis and High Blood Pressure in
ApoE–/– Background
(A) Gross view of aortas stained with Sudan red
from apoE/ and apoE/ Wip1/ mice.
(B) Quantification of aortic atherosclerotic lesions
by the en face method for apoE/ and apoE/
Wip1/ mice after 8 weeks of western diet
feeding (n = 10/10).
(C) Representative aortic root cross-sections in
apoE/ and apoE/Wip1/mice after 8 weeks
western diet feeding.
(D) Quantification of the area of lesions in
apoE/Wip1/ and apoE/mice after 8 weeks
of western diet feeding (n = 9/9).
(E) The level of free cholesterol and cholesteryl
esters was analyzed in peritoneal macrophages
obtained from apoE/ and apoE/ Wip1/
mice as described in Experimental Procedures.
(F) Systolic blood pressure after 8 weeks of
western diet feeding in apoE/ and apoE/
Wip1/ mice (n = 10). Values are mean ± SEM.
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Wip1 Controls Obesity and AtherosclerosisWe subsequently intercrossed apoE/ Wip1/ Atm+/ to
establish two groups of littermates, apoE/ Wip1/ Atm+/
and apoE/Wip1/ Atm+/+. In a similar set of breedings, we in-
tercrossed apoE/ Wip1/ p53+/ to establish apoE/
Wip1/ p53/ and apoE/ Wip1/ p53+/+mice. ApoE/
Wip1/ displayed resistance to weight gain during the course
of 8 weeks on a western diet, but deletion of a single Atm allele
resulted in significantly increased weight gain; p53 deletion did
not have any effect (Figure 4E). MRI body composition analysis
indentified significant enrichment of body fat in apoE/Wip1/
Atm+/ compared to apoE/ Wip1/ and apoE/ Wip1/
p53/ mice (Figure 4F). Analysis of Sudan red-stained aortas
showed markedly increased plaque deposits in apoE/
Wip1/ Atm+/ compared to apoE/ Wip1/ and apoE/
Wip1/ p53/ aortas (Figures 4G and 4I). Cross-sectioning of
aortas at the aortic root further revealed significantly larger
plaques in Atm heterozygous mice when compared to apoE/
Wip1/ p53/ or apoE/ Wip1/ mice (Figures 4H and 4J).
Systolic blood pressure was also significantly increased in
apoE/ Wip1/ Atm+/ when compared to apoE/ Wip1/
mice, while p53 deficiency did not provide any significant effect72 Cell Metabolism 16, 68–80, July 3, 2012 ª2012 Elsevier Inc.(Figure 4K). Overall, deletion of a single
Atm allele was sufficient to cancel the
inhibitory effects of Wip1 deficiency on
weight gain, accumulation of fat, high
blood pressure, and atherosclerosis.
Atm Controls mTOR-Dependent
Suppression of Foam Cell
Formation in Wip1-Deficient
Macrophages
Atm plays a primary role in the nucleus;
however, deletion of either of its two nu-
clear downstream targets, p53 or Chk2,
did not increase foam cell formation in
Wip1-deficient macrophages (Figure 4D).
Increasing evidence supports Atm’s rolein regulating at least two cytoplasmic signal transduction path-
ways, mediating positive regulation of NF-kB and negative of
mTOR (Alexander et al., 2010; Wu et al., 2010; Hinz et al.,
2010). To determine whether these pathways were involved,
we knocked down RelA, to inactivate NF-kB-dependent
signaling, or Tsc2, to activate the mTOR pathway (Figure S5A).
We found that reduction in the level of Tsc2, a negative regulator
of mTOR signaling, was sufficient to reverse the inhibitory effect
of Wip1 deficiency on foam cell formation (Figure 5A). We further
confirmed that the reduction in foam cell formation correlated
with reduction in the level of cholesteryl esters in apoE/
Wip1/ when compared with apoE/ macrophages in Tsc2-
dependent manner (Figure 5A, bottom panel). AMPK, a negative
regulator of mTOR, has been previously identified as regulated
by Atm in both Lkb1-dependent and independent manners
(Alexander et al., 2010). Consistent with the role of Atm-
dependent regulation of mTOR pathway, we observed an Atm-
dependent increase in AMPKphosphorylation aswell as in phos-
phorylation of AMPK downstream target ACC in apoE/
Wip1/ macrophages (Figure 5B). In line with an inhibition
of the mTOR pathway, we also found that an activating
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mTOR downstream target, S6 kinase, were reduced in an Atm-
dependent manner in Wip1-deficient macrophages (Figures 5B
and 5C). Importantly, 4E-BP1, a downstream substrate of
mTOR, was closely associated with eiF-4E in apoE/ Wip1/
hepatocytes in vivo, in a manner that was fully dependent on
the presence of a single Atm allele (Figure 5D). Thus, deletion
of Wip1 results in Atm-dependent suppression of mTOR
signaling pathway.
A previous report showed involvement of the Atm pathway in
negative regulation of Jnk kinase, a potent regulator of metabo-
lism (Schneider et al., 2006). In contrast, we consistently
observed an increase in Jnk phosphorylation in apoE/
Wip1/ macrophages (Figure 5B). mTOR has also been impli-
cated in regulation of lipid metabolism at different levels (Xu
et al., 2010; Du¨vel et al., 2010). Inhibition of mTOR resulted in
suppression of LDL receptor expression, which could potentially
reduce the uptake of oxLDL (Sharpe and Brown, 2008).
However, we observed either no difference or even a slight
increase in the expressions of oxLDL-transporting scavenger
receptors (CD204, CD68, and CD36) in apoE/Wip1/macro-
phages (Figures S6B–S6D). Furthermore, both mTOR and its
upstream regulator, AMPK, have been implicated in regulation
of LPL expression and activity (Soliman et al., 2010). Treating
cells with the lipolysis inhibitor DEUP enhanced foam cell forma-
tion in both apoE/ and apoE/ Wip1/ macrophages (Fig-
ure 4B), which was in line with the previously published effect
on lipid droplet content (Singh et al., 2009). However, DEUP
treatment failed to overcome the inhibitory effect of Wip1 defi-
ciency on foam cell formation (Figure 4B), and we observed no
differences in LPL activity between different genotypes (data
not shown). Thus, our data support the role of the Atm-mTOR
pathway in suppressing foam cell formation, independent of
Jnk, LPL, or expression of scavenger receptors.
Wip1 Controls Autophagy-Dependent Formation
of Foam Cells
Activation of Atm could result in apoptosis; however, we did not
observe apoptosis activation in apoE/ Wip1/ and apoE/
macrophages under various conditions (data not shown). Atm
and mTOR are critical regulators of autophagy that have been
recently implicated in controlling fat metabolism (Xu et al.,
2010; Alexander et al., 2010). To evaluate if autophagy was
significantly different in apoE/Wip1/ versus apoE/macro-
phages, we analyzed protein extracts for the presence of LC3-II,
the lipidated form of LC3. The LC3 conjugation system is essen-
tial for autophagy, and its membrane-bound form, LC3-II, which
is located on preautophagosomes and autophagosomes, is
commonly used as autophagosomal marker. We detected an
increase in the level of LC3-II in protein extracts from apoE/
Wip1/ but not apoE/ macrophages; this increase was
dependent on the presence of a single copy of Atm (Figure 6A).
To investigate whether elevation of LC3-II in apoE/ Wip1/
macrophages was the result of increased initiation and progres-
sion of autophagy and not the inhibition of autophagosome-
lysosome fusion or the inhibition of proteolysis, the autophagy
flux was assessed by using the colocalization analysis of tandem
fluorescent mRFP-GFP-LC3 expression vector (Figures 6B–6D)
(Kimura et al., 2007). In autophagosomes, both GFP and RFPfluorescence are colocalized (higher Pearson coefficient). In
autophagolysosomes, which are much more acidic, the green
fluorescence weakens and eventually disappears, and thus
progression to autophagolysosomes represents less colocaliza-
tion and stronger red fluorescence (lower Pearson coefficient).
We observed an Atm-dependent increase in total number
of GFP-LC3-positive as well as RFP-LC3-positive puncta in
apoE/ Wip1/ macrophages when compared to apoE/
cells (Figures 6B–6D). We further treated cells with bafilomycin
to inhibit autophagosomematuration/degradation and observed
a high level of GFP andRFP fluorescence and their colocalization
in both apoE/ Wip1/ and apoE/ cells, confirming intact
autophagic flux in apoE/ Wip1/ macrophages (Figures
6B–6D). Thus, deletion of Wip1 results in Atm-dependent activa-
tion of initiation and progression of autophagy in macrophages.
To test if increased autophagy in apoE/ Wip1/ macro-
phages could account for suppression of foam cell formation,
we next transfected cells with siRNA against Atg5 or Atg7, two
key proteins of the autophagic catabolic process. Downregula-
tion of either Atg5 or Atg7 efficiently increased foam cell forma-
tion in apoE/Wip1/ cells (Figure 6E). We further observed an
Atg5-dependent reduction in accumulation of cholesteryl esters
in apoE/ Wip1/ macrophages when compared to apoE/
cells (Figure 6E, right panel). Overall, the effects of Tsc2, Atg5,
and Atg7 siRNA suggest a role for autophagy in mediating resis-
tance to accumulation of cholesterol and thus foam cell forma-
tion in apoE/ Wip1/ macrophages.
Wip1 Controls Autophagy-Dependent Cholesterol Efflux
Reduction in cholesterol accumulation and ultimately foam cell
formation in apoE/ Wip1/ macrophages could be a result
of changes in LDL uptake or cholesterol efflux. To investigate
LDL uptake, we incubated bone marrow-derived apoE/ and
apoE/ Wip1/ macrophages with different forms of LDL.
We found that binding of LDL was comparable in different geno-
types, which was consistent with nearly equal levels of scav-
enger receptors, CD36, CD68, and CD204 (Figure S6). Analysis
of uptake further revealed no difference between apoE/ and
apoE/ Wip1/ macrophages treated with either DIL-oxLDL
or DIL-acLDL (Figure 7A).
A recent study implicated autophagy in regulation of choles-
terol efflux (Ouimet et al., 2011). To evaluate whether Wip1 is
involved in mobilizing cholesterol for efflux, macrophages
of different genotypes were loaded with acLDL containing
3H-cholesterol, and efflux of the labeled cholesterol to lipid-
poor apo-A1 and HDL was analyzed. We found that cholesterol
efflux was significantly higher from apoE/ Wip1/ macro-
phages when compared to apoE/ cells to both apo-A1 and
HDL (Figure 7B). We further found that this increase was depen-
dent on the presence of a single copy of Atm and was reduced
back to the level observed in apoE/macrophages after knock-
ing down Atg5 (Figures 7B and 7C). Differences in cholesterol
efflux could be a result of changes in expression of ATP-binding
cassette transporters; however, analysis of expression of
ABCA1, ABCG1, and SR-B1mRNA revealed no significant differ-
ences between apoE/ and apoE/ Wip1/ macrophages
(Figure S7). Previous data showed that autophagy-dependent
cholesterol efflux relies on lysosomal acid lipase (LAL) to generate
free cholesterol for efflux (Ouimet et al., 2011). To understandCell Metabolism 16, 68–80, July 3, 2012 ª2012 Elsevier Inc. 73
Figure 4. Wip1 Controls Atm-Dependent Foam Cell Formation and Atherosclerosis
(A) Reduction in foam cell formation (left panels) and accumulation of cholesteryl esters (right panel) in apoE/ Wip1/ macrophages treated with 10 mg/ml
oxidized (ox), acetylated (ac), and aggregated (ag) LDLs and VLDL.
(B) Treatment of macrophages from apoE/ and apoE/Wip1/mice with 10 mMp38 inhibitor SB202190, 10 mMAtm inhibitor Ku-55933, and 0.1 mM lipolysis
inhibitor DEUP was carried out in the presence of oxLDL, and the number of foam cells was counted 24 hr later.
(C) Analysis of the level of phosphorylation of Atm at activating site Ser1987 (human Ser1981) and p53 at Ser18 (human Ser15) was carried out in macrophages
obtained from mice of different genotypes as shown in the panel. Total level of p53 was used as a loading control.
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Figure 5. Wip1 Controls Atm-Dependent
Suppression of mTOR
(A) siRNA knockdown experiments against Tsc2
and RelA in macrophages derived from apoE/
and apoE/ Wip1/ mice followed by oxLDL
treatment. The foam cell formation (top panel) and
analysis of cholesteryl esters (lower panel) were
carried out.
(B) The level of phosphorylation of Ampk at
Thr172, ACC at Ser79, S6 kinase at Thr389, and
Jnk at Thr183/Tyr185 was analyzed in apoE/
and apoE/ Wip1/ macrophages. The level of
actin and total Jnk was used as loading controls.
(C) The level of phosphorylation of mTOR at acti-
vating site Ser2448 was analyzed in apoE/ and
apoE/ Wip1/ macrophages with and without
Atm inhibitor.
(D) Release of 4E-BP1 from eIF-4E complex in
liver extracts obtained from apoE/, apoE/
Wip1/, and apoE/ Wip1/ Atm+/ mice.
Upper panel depicts endogenous 4E-BP1 present
in total cellular lysates. Middle panel: eiF-4E eluted
from m7GTP-Sepaharose beads. Lower panel:
endogenous 4E-BP1 bound to eiF-4E. Values are
mean ± SEM.
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Wip1 Controls Obesity and Atherosclerosiswhether LAL is involved in increased cholesterol efflux from
apoE/ Wip1/ macrophages, we next analyzed efflux in the
presence of LAL-specific inhibitor compound 3a2 (ChemDiv,
USA; Ouimet et al., 2011). We found that inhibition of LAL re-
sulted in lowering the level of cholesterol efflux both to apo-A1
and HDL from apoE/ Wip1/ macrophages to the level
observed in apoE/cells (Figure7D).Wedidnot findasignificant(D) Analysis of foam cell formation (top panel) and accumulation of cholesteryl esters (bottom panel) in macro
apoE/Wip1/ Atm+/, apoE/ Wip1/ p53/, and apoE/Wip1/ Chk2/ mice.
(E) Body weight of males in apoE/ Wip1/ versus apoE/ Wip1/ Atm+/ versus apoE/Wip1/ p53
(F) Body fat composition analysis after 8 weeks western diet feeding in apoE/ Wip1/, apoE/ Wip1
(n = 8/8/8).
(G) Gross view of aortas stainedwith Sudan red from apoE/Wip1/, apoE/Wip1/Atm+/, and apoE/
feeding.
(H) Representative aortic root cross-sections obtained from apoE/ Wip1/, apoE/ Wip1/ Atm+/, an
western diet feeding.
(I) Quantitative analysis of aortic atherosclerotic lesions by the en facemethod for apoE/Wip1/, apoE/W
after 8 weeks of western diet feeding (n = 8/8/8).
(J) Quantification of the area of lesions in apoE/Wip1/, apoE/Wip1/ Atm+/, and apoE/Wip1/
(n = 8/8/7).
(K) Systolic blood pressure after 8 weeks of western diet feeding in apoE/Wip1/, apoE/Wip1/ Atm+
Values are mean ± SEM.
Cell Metabolism 16,effect of LAL inhibition on the level of
cholesterol esters in apoE/ cells (Fig-
ure 7E), which was in contrast to WT
macrophages (Ouimet et al., 2011), most
likely due to differences in the basal level
of autophagy. However, we observed
that LAL inhibition was sufficient to
reverse the inhibitory effect of Wip1 defi-
ciency on accumulation of cholesteryl
esters (Figure 7E). These data were
consistent with the effects of LAL inhibitor
on cholesterol efflux (Figure 7D). Thus, our
results extended the previously identifiedrole of autophagy in regulation of cholesterol efflux (Ouimet
et al., 2011) to show that this process involves Wip1 and Atm.
DISCUSSION
In this work, we extended the previously identified role of Wip1
phosphatase in tumorigenesis to show that it is critically involvedphages obtained from apoE/, apoE/Wip1/,
/ backgrounds fed with western diet(n = 8/8/8).
/ Atm+/, and apoE/ Wip1/ p53/ males
Wip1/ p53/mice after 8 weeks of western diet
d apoE/ Wip1/ p53/ mice after 8 weeks of
ip1/ Atm+/, and apoE/Wip1/ p53/mice
p53/mice after 8 weeks of western diet feeding
/, and apoE/Wip1/ p53/males (n = 8/8/8).
68–80, July 3, 2012 ª2012 Elsevier Inc. 75
Figure 6. Wip1 Controls Autophagy-Dependent Foam Cell Formation
(A) Analysis of LC3 forms in bonemarrow-derivedmacrophageswas carried out in different genotypes as indicated. Different forms of LC3 are shownwith arrows.
The level of b-tubulin was used as a loading control.
(B) Bone marrow-derived macrophages from apoE/ and apoE/ Wip1/ mice were transfected with mRFP-GFP-LC3 expression vector (obtained from
Addgene), and autophagic flux was analyzed in different genetic backgrounds. Representative images are shown for different conditions.
(C) Pearson coefficient for different genotypes was analyzed as described in Experimental Procedures. Higher Pearson coefficient corresponds to higher level of
colocalization of mRFP and GFP, lower to accumulation of RFP and thus autophagolysosomes.
(D) The average number of GFP-LC3 (top) and RFP-LC3 (bottom) puncta quantified per cell in apoE/ and apoE/ Wip1/ macrophages transfected with
mRFP-GFP-LC3 vector with and without bafilomycin treatment (400 nM, 6 hr). The analysis was done with the MATLAB software.
(E) siRNA knockdown experiments against Atg5 and Atg7 in macrophages derived from apoE/ and apoE/Wip1/mice followed by oxLDL treatment. The
foam cell formation (left panel) and analysis of cholesteryl esters (right panel) were carried out. Values are mean ± SEM.
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Figure 7. Wip1 Controls Autophagy-Depen-
dent Cholesterol Efflux
(A) Uptake of DIL-oxLDL and DIL-acLDL was
analyzed in apoE/ and apoE/ Wip1/
macrophages as described in Experimental
Procedures. ns stands for not significant.
(B) LXR-dependent cholesterol efflux (in % as
described in Experimental Procedures) to BSA,
apo-A1, and HDL was analyzed in macrophages
of different genotype as indicated in the panel.
(C) LXR-dependent cholesterol efflux (%) to BSA,
apo-A1, and HDL was analyzed in apoE/ and
apoE/ Wip1/ macrophages with and with-
out Atg5.
(D) LXR-dependent cholesterol efflux (%) to BSA,
apo-A1, and HDL was analyzed in apoE/ and
apoE/Wip1/macrophages in the presence of
10 mM LAL inhibitor (compound 3a2, ChemDiv,
USA) (Ouimet et al., 2011).
(E) Accumulation of cholesteryl esters in bone
marrow-derived apoE/ and apoE/ Wip1/
macrophages was analyzed in the presence of
10 mM LAL inhibitor. Cells were preloaded with
acLDL/cholesterol and subsequently incubated
with apo-A1 and LAL inhibitor as described
for cholesterol efflux experiments. Values are
mean ± SEM.
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Wip1 Controls Obesity and Atherosclerosisin regulating diet-induced fat accumulation and atherosclerosis,
by demonstrating that Wip1 deletion prevents both conditions.
Both Atm and p53 have been previously linked to atheroscle-
rosis. Deletion of Atm reportedly increases lesions in chow-fed
mice on an apoE/ background (Wu et al., 2005; Schneider
et al., 2006). p53 has also been implicated in regulation of athero-
genesis in several mouse models (Guevara et al., 1999; van
Vlijmen et al., 2001). Interestingly, both Atm and p53 have also
been linked to regulation of Jnk kinase, a key regulator of fat
accumulation and atherosclerosis (Schneider et al., 2006; Evans
et al., 2002). Surprisingly, however, we found that in Wip1-
deficient macrophages that had both Atm and p53 activated,
the level of Jnk phosphorylation was not reduced but upregu-
lated (Figure 5B). Despite an increase in Jnk, Wip1 deficiency
resulted in suppression of fat accumulation and atherosclerosis
in apoE/mice, which appeared to be fully dependent on Atm,
but not p53 (Figures 4E–4K).
Numerous downstream targets of Atm have been identified in
the nucleus, and increasing evidence suggests that Atm has anCell Metabolism 16,important role in the regulation of at least
two cytoplasmic signaling pathways, NF-
kB and mTOR (Wu et al., 2005, 2010;
Alexander et al., 2010). NF-kB has an es-
tablished role in the positive regulation of
atherosclerosis (Hansson and Libby,
2006), and thus upregulation of this
pathway in Wip1-deficient mice (Chew
et al., 2009) should worsen the effect of
apoE deletion. In fact, Wip1-deficient
mice do show enhanced immune
response (Choi et al., 2002), which is an
integral part of atherosclerosis; however,
they are resistant to both weight gain andformation of atherosclerotic lesions when fed with a high-fat diet
(Figures 1 and 3). This may suggest that Wip1-dependent modu-
lation of the Atm-mTOR pathway could potentially overcome the
atherogenic effect of active Jnk and/or NF-kB.
Several reports have highlighted the significance of the mTOR
pathway in the regulation of atherosclerosis. Injection of Ldlr/
mice with everolimus, an inhibitor of mTOR, resulted in a signifi-
cant reduction of atherosclerotic lesions, which was associated
with a delayed transition from early macrophage-enriched
lesions to advanced atherosclerotic plaques (Mueller et al.,
2008). In another study, activation of AMPK by synthetic poly-
phenol protected against hepatic steatosis and accelerated
atherosclerosis in diet-induced insulin-resistant LDL receptor-
deficient mice (Li et al., 2011). Thus, inactivation of the mTOR
pathway, either through modulation of Atm (present work) or
with the chemical inhibitors, could provide interesting avenues
for treating atherosclerosis.
Previous studies have shown that vascular smooth muscle
cells, macrophages, or endothelial cells treated in vitro with68–80, July 3, 2012 ª2012 Elsevier Inc. 77
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Wip1 Controls Obesity and Atherosclerosisproatherogenic stimuli exhibit certain features typical of autoph-
agy, such as LC3 processing, formation of myelin figures, and
extensive vacuolization (Martinet andDeMeyer, 2008). Recently,
progressive plaque formation has been shown to have features
of defective autophagy predominantly related to plaque macro-
phages (Razani et al., 2012). The effect of autophagy on fat
accumulation in vivo, however, is complex, and the data require
very careful interpretation. While it was reported that genetic
knockdown of Atg5 markedly increased TG and cholesterol
content in hepatocytes (Singh et al., 2009), ablation of another
autophagic gene, Atg7, reduced body weight because of a
marked reduction in the mass of white adipose tissue (Singh
et al., 2009a; Zhang et al., 2009). In the latter case, however,
the effect of lost autophagy on LDs was secondary to a failure
of the cells to differentiate into white adipocytes and thus does
not rule out a lipolytic function for autophagy in mature
adipocytes.
Our data extend the previously identified role of autophagy in
regulation of cholesterol efflux (Ouimet et al., 2011) to show that
this process also involvesWip1 andAtm. Previous report showed
that autophagy-mediated efflux is closely linked to the ATP-
binding cassette (ABC) reporter ABCA1 (Ouimet et al., 2011). In
the absence of autophagy, efflux to apo-A1 is nearly completely
abolished and significantly reduced to HDL. ABCA1 mediates
a unidirectional transport, mostly to apo-A1 (Wang et al., 2000).
HDL-mediated efflux is a bidirectional, diffusional process that
involves multiple transporters and represents a much more
complex pathway for which the contribution of autophagy
remains to be studied in great detail (Rothblat and Phillips,
2010). In turn, we now show that deletion of Wip1 results in
increase incholesterol effluxboth toapo-A1andHDL, theprocess
that appeared to be dependent on Atm, Atg5, and LAL (Figure 7).
Autophagy-dependent cholesterol efflux in Wip1-deficient
macrophages relies on LAL to generate free cholesterol for efflux
(Figures 7D and 7E), and this mechanism may be particularly
relevant to the reversal of early atherosclerotic lesions. At early
stages cholesterol is predominantly accumulated in cytosolic
LDs (Stary et al., 1994) while trapped in lysosomes in advanced
atherosclerotic plaques (Jerome, 2006). Wip1 deficiency attenu-
ates early foam cell formation, thus delaying atherosclerosis
even in mice that have been on a fat diet for 14 weeks. In light
of recent data showing features of defective autophagy in
advanced stages of atherosclerosis (Razani et al., 2012), it would
be interesting to know if Wip1 inactivation, conditionally or with
a drug at later stages of atherosclerosis, would have a significant
protective effect. Our results could argue that Wip1 would play
a role in progression of advanced lesions through its ability to
modulate both mTOR signaling pathway (Figure 5) and autoph-
agy (Figure 6). Even in the absence of any cytoplasmic LDs, as
in foam cells of advanced atherosclerotic plaques, there is an au-
tophagy-attributable efflux to apo-A1 (Ouimet et al., 2011), while
the systemic administration of mTOR inhibitors has been shown
to attenuate plaque progression (Pakala et al., 2005).
In summary, our analysis of Wip1-deficient mice and foam cell
formation revealed the important role of Wip1 phosphatase in
regulation of autophagy-dependent cholesterol efflux through
an Atm-mTOR-dependent signaling pathway. Thus, our findings
suggest interesting prospects for developing drugs to treat
obesity and atherosclerosis.78 Cell Metabolism 16, 68–80, July 3, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
Animals
All animal protocols used in this study were approved by the Institute of
Molecular and Cell Biology Animal Safety and Use Committee. Wip1/ and
p53/ mice have been previously described (Donehower et al., 1992;
Choi et al., 2002). Atm+/ mice and apolipoprotein E (apoE)/ mice (both in
C57BL/6J background) were obtained from the Jackson Laboratory. Wip1/
mice were backcrossed >6 generations in C57BL/6 background before
being used for analysis. ApoE/ Wip1/ p53+/ were interbred to generate
littermates with the following genotypes: apoE/ Wip1/ p53/ and
apoE/ Wip1/. ApoE/ Wip1/ Atm+/ were interbred to generate
apoE/ Wip1/ and apoE/ Wip1/ Atm+/ littermates. For western diet
sex-matched littermates of 6–8 weeks of age were placed on western diet
containing 0.15% cholesterol providing 42% kcal in fat (TD 88137, Harlan)
or, when indicated, on a high-fat diet providing 60% kcal in fat (TD 06414,
Harlan) and analyzed 8 weeks later.
Foam Cell Formation and Analysis
For each mouse, bone marrow was flushed out from the femurs and tibias
with phosphate-buffered saline (PBS). Cells were plated and differentiated
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum, 2 mmol/l glutamine, 30% L929 cell-conditioned media
(as a source of macrophage-colony stimulating factor), and penicillin-
streptomycin for 5 days. Fresh media was replaced and cells were used
by day 9. Macrophages were then incubated for 24 hr with 10 mg/ml oxLDL
(Intracel) in DMEM supplemented with 10% fetal bovine serum, 2 mmol/l
glutamine. Cells were then washed in PBS, fixed in 2% formaldehyde and
0.2% glutaraldehyde in PBS for 15 min, and then rinsed in PBS, water, and
60% isopropanol. Cells were then stained with oil red O and rinsed in 60%
isopropanol and water. Multiple images were then taken, and the per-
centage of stained cells was quantified. The three random independent
locations were used for one experiment repeated over three independent
experiments for the final calculation and comparison. To assess macro-
phage differentiation, the FACS analysis was performed by blocking Fc
receptor with Mouse Fc Block (BD) followed by incubation with Cd11b-
FITC (BD).
Autophagic Flux
Bone-marrow derived macrophages (BMDM) were seeded on poly-lysine-
treated slides, transfected with tandem fluorescent mRFP-GFP-LC3 plasmid
(Addgene) using polymag transfection reagent (Ozbioscience), and incubated
overnight in DMEM medium supplemented with nonessential amino acids
(2 mmol/l), L-glutamine (2 mmol/l), streptomycin (100 mg/ml), and penicillin
(100 IU/ml). Cell were washed the next day in PBS and replaced with DMEM
supplemented with 1% delipidated and charcoal-stripped FBS and treated
with oxLDL or acLDL (10 mg/ml). Twenty-four hours later, cells were washed
in PBS and replaced with serum-free medium supplemented with BSA
(2 mg/ml) for overnight incubation. The next day cells on coverslips were fixed
with 4% PFA/0.1%GA for 15min, washed with PBS, and mounted. Cells were
examined using confocal microscopy for mRFP and GFP fluorescence.
Colocalization of mRFP and GFP was analyzed using ImageJ software.
Pearson’s R values are plotted for each treatment condition; >20 cells were
analyzed for each population.
Statistical Analysis
Values are mean ± SEM; n is indicated in the figure legend. Comparison of
mean values between group was evaluated by two-tailed Student’s t test
or ANOVA where indicated. A p value less than 0.05 was considered sig-
nificant. In all experiments, the number of asterisks represent the following:
*** p < 0.001, **p < 0.01, *p < 0.05.
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